U.S. ARMY MED. RESEARCH ACQUISITION ACT, MCMR-RMA (PGI-2), FORT DETRICK BLDG. 820, FREDERICK MD 21702-5014

A -- R&D STREAMLINED CONTRACT SOL DAMD17-95-#-0009 DUE 052495 POC CRAIG D. LEBO, 301-619-2036 Pyridostigmine Bromide Studies Persian Gulf War Illnesses (PGI-2) The U.S. Army Medical Research and Materiel Command (USAMRMC) on behalf of the Departments of Defense, Veteran's Affairs and Health and Human Services Cooperative Research Program, is supporting Pyridostigmine studies of possible health consequences of military service or employment in the Southwest Asia theater of operations during the Persian Gulf War. The USAMRMC is seeking proposals to determine whether the use of pyridostigmine bromide alone as a pretreatment against nerve agents, or combined with exposures to pesticides, other organophosphorous compound, caramates or other relevant chemicals would result in increased toxicity. No conventional solicitation will be issued for this action, but the details of the requirements will appear in a future edition of the Commerce Business Daily (CBD). This action follows the guidelines of the R&D streamlined contracting procedure outlined in DFARS 235.7000. Any offeror desiring to receive any amendments to this solicitation and any supplemental packages, if developed, should send their name and address, citing this announcement to the issuing office. (0125)

Loren Data Corp. http://www.ld.com (SYN# 0003 19950508\A-0003.SOL)